November 12, 2024
Loading...
You are here:  Home  >  Latest news  >  Current Article

MannKind takes next step in rebuild with new FDA approval

IN THIS ARTICLE

MannKind employees including CEO Michael Castagna, center, ring the opening bell of the Nasdaq on May 23. (courtesy photo) Five years ago, MannKind Corp. was in bad shape. With barely enough capital to fund its operations through August of 2017, a ton of debt and no real product pipeline, new CEO Michael Castagna, who took…

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.